Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibiotics
antibiotics
Pharma's niche focus spurs US aid for antibiotics
Yahoo/AP
Wed, 01/25/12 - 11:06 am
antibiotics
R&D
innovation
Insmed shares spike after FDA lifts hold
Fierce Biotech
Tue, 01/24/12 - 11:19 am
Insmed
FDA
Arikace
antibiotics
Cubicin Drives Cubist Pharma
Yahoo/Zacks
Sat, 01/21/12 - 12:02 pm
Cubicin
Cubist Pharmaceuticals
antibiotics
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Yahoo/MarketWire
Sat, 01/7/12 - 01:25 pm
Theravance
Astellas
Vibativ
antibiotics
J&J Halts Study of Doribax Antibiotic on Higher Death Rate
Bloomberg
Fri, 01/6/12 - 11:50 am
JNJ
Doribax
antibiotics
Rib-X touts positive PhIIb antibiotic data
Fierce Biotech
Thu, 12/15/11 - 07:35 pm
antibiotics
Rib-X Pharmaceuticals
delafloxacin
Mylan Wins Ruling Overturning Generic Doryx Antibiotic Ban
Bloomberg
Mon, 12/12/11 - 12:25 pm
generics
Mylan
DORYX
antibiotics
Warner Chilcott
TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin
Sacramento Bee, Ca
Sat, 12/10/11 - 01:02 pm
TaiGen
Nemonoxacin
antibiotics
Lupin gets U.S. nod for oral antibiotic, shares up
Yahoo/Reuters
Fri, 12/2/11 - 09:34 am
Lupin
antibiotics
Solodyn
Medicis
Sanofi antibiotics partner Rib-X aims for $80M IPO
Fierce Biotech
Tue, 11/29/11 - 09:11 am
Sanofi
antibiotics
Rib-X Pharmaceuticals
IPO
Antibiotics overprescribed for children: study
Reuters
Wed, 11/9/11 - 11:57 am
antibiotics
pediatrics
Lack of antibiotic research a looming crisis
The Day, CT
Sun, 10/30/11 - 12:50 pm
antibiotics
GAIN Act
Astra, Forest to start Phase 3 superbug drug study
Reuters
Tue, 10/18/11 - 08:59 am
AstraZeneca
Forest Labs
CAZ-AVI
antibiotics
superbugs
J&J Unit Cleared of Liability for Alleged Levaquin Injuries
Bloomberg
Fri, 10/14/11 - 11:37 am
JNJ
antibiotics
Levaquin
Ortho-McNeil-Janssen
Antibiotics developer Cempra braves tough market with $86M IPO
Fierce Biotech
Thu, 10/13/11 - 01:32 pm
antibiotics
Cempra
IPO
J&J Didn’t Warn Levaquin Riskier Than Rivals, Lawyer Argues
Bloomberg
Thu, 10/13/11 - 10:53 am
JNJ
antibiotics
Levaquin
Ortho-McNeil-Janssen
More Drugs Mean More Disease as China Fails to Control Use of Antibiotics
Bloomberg
Thu, 10/6/11 - 11:58 am
China
antibiotics
Warner Chilcott Wins Court Ruling Blocking Mylan Copy of Doryx Antibiotic
Bloomberg
Thu, 09/22/11 - 09:12 am
Mylan
antibiotics
DORYX
Warner Chilcott
generics
Neglected Bacteria Give Cubist $2B Market
Bloomberg
Thu, 09/15/11 - 09:40 am
antibiotics
Cubist Pharmaceuticals
CXA-201
gram negative bacterial infections
J&J Failed to Warn About Tendon Risk From Antibiotic Levaquin, Lawyer Says
Bloomberg
Tue, 09/6/11 - 05:57 pm
Levaquin
JNJ
antibiotics
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
next ›
last »